logo

OCTOBER 29-NOVEMBER 2, 2017
COLORADO CONVENTION CENTER
DENVER, COLORADO

Satellite programs offer sponsors the opportunity to provide professional attendees with comprehensive insights into important interventional topics and issues facing today's specialists. The satellite program schedule is comprised of Breakfast Meetings, Presentation Theater Programs (lunch sessions), and Evening Programs.

 

Satellite Programs

Left Atrial Appendage Closure: Outstanding Data, Outstanding Questions

Presentation Theater Program

10/30/2016 13:00:00 10/30/2016 14:00:00 Left Atrial Appendage Closure: Outstanding Data, Outstanding Questions TCT 2017 true MM/DD/YYYY TCT 2014 Satellite Symposia - Presentation Theater Program

Sunday, October 30, 2016
Program: 1:00 pm-2:00 pm
Walter E. Washington Convention Center, Washington, D.C., Presentation Theater 2

Left Atrial Appendage Closure: Outstanding Data, Outstanding Questions

Left Atrial Appendage Closure: Outstanding Data, Outstanding Questions

Sponsored by Cardiovascular Research Foundation

Supported through an educational grant from SentreHEART, Inc.

The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cardiovascular Research Foundation designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Chair  

William A. Gray, MD

Main Line Health

Wynnewood, PA

Faculty  

Ori Ben-Yehuda, MD

Cardiovascular Research Foundation

New York, NY

 

Dhanunjaya (DJ) Lakkireddy, MD

University of Kansas Medical Center

Kansas City, KS

 

Robert J. Sommer, MD

NewYork-Presbyterian Hospital/Columbia University Medical Center

New York, NY

 

Steven J. Yakubov, MD

Riverside Methodist Hospital

Columbus, OH

Agenda

1:00 pm

Welcome and Introductions

William A. Gray

1:05 pm

Left Atrial Appendage Occlusion (LAAO) in OAC-Ineligible Patients: Who Should Be Considered and How Common Are They?

Ori Ben-Yehuda

1:17 pm

Does the Availability of Novel/Alternative Oral Anticoagulants Change the Conclusions from the Watchman Trial Data?

Robert J. Sommer

1:29 pm

Are there Opportunities to Improve on the Watchman Outcomes? Current and Future Device Approaches

Steven J. Yakubov

1:41 pm

Ligation Meets Ablation: Early Data on the Synergistic Effects of PV Ablation with LAA Ligation and the AMAZE Trial

Dhanunjaya (DJ) Lakkireddy

1:53 pm

Discussion

2:00 pm

Adjourn